| scholarly article | Q13442814 |
| P50 | author | Martin Pera | Q42680883 |
| P2093 | author name string | Wangde Dai | |
| Michael Rubart | |||
| Robert A Kloner | |||
| Loren J Field | |||
| Sharon L Hale | |||
| Robert Zweigerdt | |||
| Alan Colman | |||
| Aarne J Jyrala | |||
| Gregory L Kay | |||
| Bruce P Davidson | |||
| Sean Reuter | |||
| Ralph E Graichen | |||
| P2860 | cites work | Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells | Q44145594 |
| Cellular basis of abnormal calcium transients of failing human ventricular myocytes | Q44324582 | ||
| Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction | Q44392643 | ||
| Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes | Q44970476 | ||
| Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice | Q45171605 | ||
| Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers | Q45196010 | ||
| Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up | Q46711448 | ||
| Long-term outcome of fetal cell transplantation on postinfarction ventricular remodeling and function | Q47858951 | ||
| Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. | Q51348173 | ||
| Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. | Q54662680 | ||
| Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings | Q61654826 | ||
| Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium | Q72321699 | ||
| Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation | Q73105476 | ||
| Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function | Q77900427 | ||
| Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines | Q80264618 | ||
| Cardiac cell therapy--mixed results from mixed cells | Q80312247 | ||
| Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study | Q81228975 | ||
| Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement | Q83043116 | ||
| Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium | Q24677311 | ||
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes | Q28345594 | ||
| Two-photon molecular excitation imaging of Ca2+ transients in Langendorff-perfused mouse hearts | Q30886586 | ||
| Two-photon microscopy of cells and tissue | Q31135361 | ||
| Differentiation and long-term survival of C2C12 myoblast grafts in heart | Q33903190 | ||
| Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts | Q34387398 | ||
| Targeted deletion of keratins 18 and 19 leads to trophoblast fragility and early embryonic lethality | Q34489780 | ||
| Pluripotency of spermatogonial stem cells from adult mouse testis | Q34505738 | ||
| Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages | Q34579177 | ||
| Embryonic stem cells share immune-privileged features relevant for tolerance induction | Q34694308 | ||
| Allogeneic stem cells, clinical transplantation and the origins of regenerative medicine | Q34786951 | ||
| Myocyte and myogenic stem cell transplantation in the heart | Q35131739 | ||
| Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host | Q35146911 | ||
| Formation of human myocardium in the rat heart from human embryonic stem cells | Q35221817 | ||
| Stem cell therapy for the heart | Q35980614 | ||
| Cardiac repair by embryonic stem-derived cells | Q36349185 | ||
| Stem cell transplantation for the treatment of myocardial infarction | Q36368239 | ||
| Cardiac regeneration: repopulating the heart | Q36387864 | ||
| Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation | Q37511101 | ||
| Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. | Q40173892 | ||
| Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes | Q40283525 | ||
| Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium | Q40374007 | ||
| Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. | Q40395995 | ||
| Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures | Q40417055 | ||
| The hESC line Envy expresses high levels of GFP in all differentiated progeny. | Q40443780 | ||
| Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. | Q40479961 | ||
| Human embryonic stem cells possess immune-privileged properties | Q40531152 | ||
| Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes | Q40550123 | ||
| Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization | Q40641800 | ||
| Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells | Q40648427 | ||
| Selection of ventricular-like cardiomyocytes from ES cells in vitro | Q40782917 | ||
| Visceral-endoderm-like cell lines induce differentiation of murine P19 embryonal carcinoma cells | Q41698260 | ||
| Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies | Q42798412 | ||
| Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects | Q43697103 | ||
| P433 | issue | 4 | |
| P921 | main subject | human embryonic stem cell | Q59626782 |
| P304 | page(s) | 504-516 | |
| P577 | publication date | 2007-07-14 | |
| P1433 | published in | Journal of Molecular and Cellular Cardiology | Q2061932 |
| P1476 | title | Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts | |
| P478 | volume | 43 |
| Q88176627 | Applications of genetically engineered human pluripotent stem cell reporters in cardiac stem cell biology |
| Q45291527 | Approaches to Improving Cardiac Structure and Function During and After an Acute Myocardial Infarction: Acute and Chronic Phases |
| Q47270959 | Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application |
| Q38519839 | Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering |
| Q38152417 | Biomimetic materials design for cardiac tissue regeneration. |
| Q50503080 | CREG1 Interacts with Sec8 to Promote Cardiomyogenic Differentiation and Cell-Cell Adhesion. |
| Q24615347 | Cardiac applications for human pluripotent stem cells |
| Q37800141 | Cardiac cell therapies: the next generation |
| Q35144550 | Cardiac cell therapy: where we've been, where we are, and where we should be headed |
| Q39747622 | Cardiac differentiation of pluripotent stem cells |
| Q37832530 | Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models |
| Q36996270 | Cell tracing techniques in stem cell transplantation |
| Q41375244 | Cell-based delivery of dATP via gap junctions enhances cardiac contractility |
| Q33690013 | Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo. |
| Q38063849 | Concise review: cell therapy and tissue engineering for cardiovascular disease |
| Q27004753 | Current stem cell delivery methods for myocardial repair |
| Q38000939 | Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells |
| Q39216651 | Differentiation of human ES cell line KIND-2 to yield tripotent cardiovascular progenitors |
| Q37542604 | Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells |
| Q37313292 | Embryonic Stem Cells as a Model for Cardiac Development and Disease |
| Q37992937 | Embryonic stem cells for severe heart failure: why and how? |
| Q37737762 | Emerging use of stem cells in regenerative medicine. |
| Q36822815 | Engineered human cardiac tissue |
| Q37640657 | Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. |
| Q39685694 | Enhancement of cardiomyocyte differentiation from human embryonic stem cells |
| Q37049458 | Exogenous Nitric Oxide Protects Human Embryonic Stem Cell-Derived Cardiomyocytes against Ischemia/Reperfusion Injury |
| Q38001505 | Experience from experimental cell transplantation therapy of myocardial infarction: what have we learned? |
| Q39672326 | Experimental Cell Transplantation Therapy in Rat Myocardial Infarction Model Including Nude Rat Preparation |
| Q33572148 | Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes |
| Q37710740 | Fast and efficient multitransgenic modification of human pluripotent stem cells. |
| Q33941198 | Generation of human female reproductive tract epithelium from human embryonic stem cells. |
| Q34355730 | Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats |
| Q33726792 | Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function |
| Q37023827 | Human embryonic stem cells and cardiac repair |
| Q37262393 | Human embryonic stem cells for cardiomyogenesis |
| Q41231682 | Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. |
| Q38041929 | Induced pluripotent stem cells for cardiac repair |
| Q38203865 | Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. |
| Q37088302 | Injection of isolated mitochondria during early reperfusion for cardioprotection |
| Q33734315 | Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue |
| Q37043528 | Logistics of stem cell isolation, preparation and delivery for heart repair: concerns of clinicians, manufacturers, investors and public health. |
| Q34670000 | Long-Term Improvement in Postinfarct Left Ventricular Global and Regional Contractile Function Is Mediated by Embryonic Stem Cell–Derived Cardiomyocytes |
| Q34087548 | Marching towards regenerative cardiac therapy with human pluripotent stem cells |
| Q37608606 | Mesenchymal stromal cell and mononuclear cell therapy in heart disease |
| Q37626836 | Mesenchymal stromal cells for cardiovascular repair: current status and future challenges |
| Q48028186 | Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium |
| Q33875374 | Pluripotent stem cell derived cardiomyocytes for cardiac repair |
| Q36855438 | Pluripotent stem cells for cardiac regeneration: overview of recent advances & emerging trends |
| Q37824305 | Potential of human embryonic stem cells in cartilage tissue engineering and regenerative medicine. |
| Q45290478 | Rebuilding the infarcted heart with noncellular material |
| Q90670805 | Regulation of cardiomyocyte maturation during critical perinatal window |
| Q92689430 | Sonic Hedgehog upregulation does not enhance the survival and engraftment of stem cell-derived cardiomyocytes in infarcted hearts |
| Q37183624 | Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies. |
| Q37164041 | Stem-cell-based therapy and lessons from the heart |
| Q41272675 | Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells |
| Q36807952 | Structural coupling of cardiomyocytes and noncardiomyocytes: quantitative comparisons using a novel micropatterned cell pair assay. |
| Q38177694 | The Therapeutic Effect of Cell Transplantation Versus Noncellular Biomaterial Implantation on Cardiac Structure and Function Following Myocardial Infarction |
| Q85712638 | The role of slingshot-1L (SSH1L) in the differentiation of human bone marrow mesenchymal stem cells into cardiomyocyte-like cells |
| Q37342534 | Update: cardiac xenotransplantation. |
| Q35923401 | Uses of cardiomyocytes generated from induced pluripotent stem cells |
| Q34644744 | Utility of dual-modality bioluminescence and MRI in monitoring stem cell survival and impact on post myocardial infarct remodeling |
Search more.